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Background: Checklists are clinical decision support tools that improve process of care and patient outcomes.
We previously demonstrated that prompting critical care physicians to address issues on a daily rounding checklist
that were being overlooked reduced utilization of empiric antibiotics and mechanical ventilation, and reduced
risk-adjusted mortality and length of stay. We sought to examine the degree to which these process of care
improvements explained the observed difference in hospital mortality between the group that received prompting
and an unprompted control group.
Methods: In the medical intensive care unit (MICU) of a tertiary care hospital, we conducted face-to-face
prompting of critical care physicians if processes of care on a checklist were being overlooked. A control MICU
team used the checklist without prompting. We performed exploratory analyses of the mediating effect of empiric
antibiotic, mechanical ventilation, and central venous catheter (CVC)duration on risk-adjusted mortality.
Results: One hundred forty prompted group and 125 control group patients were included. One hundred
eighty-three patients were exposed to at least one day of empiric antibiotics during MICU admission. Hospital
mortality increased as empiric antibiotic duration increased (P<0.001). Prompting was associated with shorter
empiric antibiotic duration and lower risk-adjusted mortality in patients receiving empiric antibiotics (OR 0.41,
95% CI 0.18-0.92, P=0.032). When empiric antibiotic duration was added to mortality models, the adjusted OR for
the intervention was attenuated from 0.41 to 0.50, suggesting that shorter duration of empiric antibiotics explained
15.2% of the overall benefit of prompting. Evaluation of mechanical ventilation was limited by study size.
Accounting for CVC duration changed the intervention effect slightly.
Conclusions: In this analysis, some improvement in mortality associated with prompting was explained by shorter
empiric antibiotic duration. However, most of the mortality benefit of prompting was unexplained.
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Checklists are clinical decision support tools that
improve patient care [1-5]. We have previously shown
that prompting physicians to use a daily rounding check-
list was associated with a reduced risk-adjusted mortality
odds ratio of 0.34 and reduced risk-adjusted ICU length
of stay [6]. The intervention was associated with several
process of care improvements, including reduced em-
piric antibiotic utilization, that may have contributed to
these benefits [6]. Empiric antibiotic therapy—defined as
antibiotics administered without culture-documented in-
fection—is frequently administered even when the likeli-
hood of infection is low [6,7]. Overuse of empiric
antibiotics can lead to super infection or antibiotic
resistance, and may increase mortality [8,9]. Even in
study populations where infection was highly suspected,
strategies to reduce theduration of antibiotics based
on the biomarker procalcitonin shortened antibiotic
therapy in the intensive care unit (ICU) and did not
appear to worsen mortality (though these studies were
small) [10-12].
In our study, prompting was also associated with
shorter central venous catheter duration and increased
ventilator-free days [6]. Previous studies have reported
that interventions to reduce the duration of mechanical
ventilation or central venous catheters are associated
with improved outcomes [13-17].
It is important to understand which of these processes
of care improvements contributed to lower mortality in
the group that received prompting. The objective of the
present study was to perform post hoc exploratory anal-
yses to examine if differences in care components
addressed by the checklist—specifically empiric anti-
biotic duration, mechanical ventilation, and central ven-
ous catheter duration—were mediators of the observed
difference in hospital mortality between the intervention
group that received prompting and the unprompted
control group. In addition, we sought to investigate the
relationship between empiric antibiotic duration and
mortality independent of the effect of group assignment.
Methods
Study design
Some of the details of the methods used in this study
have been previously reported [6]. In brief, we con-
ducted an investigation among two medical ICU
(MICU) teams at Northwestern Memorial Hospital, a
tertiary care urban hospital affiliated with an academic
medical center. This study was approved by the North-
western University Institutional Review Board with a
waiver of consent (study number: STU00013313). The
MICU is a closed unit staffed by two teams, each with
an independent patient census. The two teams admit
patients on alternating days and are comprised of onepulmonary/critical care attending physician, one fellow,
one pharmacist, and several residents and interns. Attend-
ings and fellows have weekday rotations of 1–4 weeks, fre-
quently with different weekend coverage. Physicians were
arbitrarily assigned to the two MICU teams prior to and
without knowledge of the study. At the onset of the study,
which team was assigned to prompting was randomly
chosen—team membersdid not choose to be part of the
prompted or control teams.
A MICU daily rounding checklist was instituted in
March 2009 for both teams as a quality improvement
tool. It was designed to address process of care issues
not directly related to the primary illness and therefore
potentially overlooked.
Intervention
From June 25 to September 15, 2009, one MICU team
(prompted team) was assigned to receive an intervention
that consisted of prompting during daily rounds for all
patients under their care. A non-care providing resident
physician (the prompter) initiated discussion with the
attending physician on the prompted team during daily
bedside rounds if any of the following six parameters
under investigation were overlooked: empiric antibiotic
utilization, mechanical ventilation weaning, central ven-
ous catheters (CVCs), Foley urinary catheters, and deep
vein thrombosis (DVT) and stress ulcer prophylaxis. For
example, if the rounding team failed to discuss the
utilization or discontinuation of empiric antibiotics, the
prompter would ask, “The patient has been on [empiric
antibiotic] for [X]days. Do you want to continue it?” The
prompters had no patient care responsibilities; there was
no contact between the prompters and any patient. The
second MICU team was unprompted, but continued to
have the identical checklist available, and served as a
concurrent control.
The following patients were excluded from analysis:
1) patients physically located in adifferent ICU for more
than the first 72 hours of their ICU stay, 2) patients
transferred from a different ICU service (e.g. surgical
ICU), and 3) patients transferred to a different ICU ser-
vice within 12 hours of MICU admission. Also, only the
first MICU admission was included for patients admitted
more than once without intervening hospital discharge
[18,19]. Any patient admitted to the prompted team
was included regardless of whether the prompter was
present during their ICU stay. Prompting began during
the first rounds after a patient’s MICU admission and
continued daily (whenever the prompter was present)
until MICU discharge.
Measurement of care processes and outcomes
Empiric antibiotics were defined as antibiotics adminis-
tered without culture-documented infection. Central






Age (years), mean (SD) 58.5 (17.8) 57.3 (17.8) 0.60
Gender (male), no. (%) 69 (49.3) 51 (40.8) 0.17
Race, no. (%)
White 71 (50.7) 69 (55.2)
African American 47 (33.6) 42 (33.6) 0.54
Hispanic/Other 22 (15.7) 14 (11.2)
Mechanical Ventilation,
no. (%)
36 (28.8) 41 (29.3) 0.93
APACHE IV predicted
hospital mortality, no. (%)
31.1 (22.2) 27.2 (21.7) 0.86
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ipherally inserted central catheters (PICCs). Hospital mor-
tality was collected from the hospital’s electronic health
record. In order to perform risk adjustment, data necessary
to calculate Acute Physiology and Chronic Health Evalu-
ation (APACHE) IV predicted hospital mortality and ICU
LOS within the first 24 hours of MICU admission were
collected and scored retrospectively [18,19]. These data
were collected by personnel blinded to group assignment.
Care process duration for empiric antibiotics and cen-
tral venous catheters was categorized into 1–3days (Cat-
egory 1), 4–6days (Category 2), and ≥7days (Category 3).
A 72 hour cutoff for Category 1 was chosen because this
interval is shorter than the threshold of increased risk of
ventilator-associated pneumonia, central line-associated
bloodstream infection, and urinary catheter-related in-
fection [20-22]; approximately the time point at which
de-escalation of empiric antibiotics is considered [23];
and approximately when final bacterial culture results
become available in our laboratory. To test whether
our findings were sensitive to the empiric antibiotic cat-
egories we chose, we performed an additional analysis
with empiric antibiotic duration categories of 1–3days,
4–5days, and ≥6days.
Analytic plan
Three care processes—empiric antibiotic duration, days
alive and ventilator-free within the first 28 days after ini-
tiation of mechanical ventilation, and central venous
catheter duration—differed significantly between the
prompted and control groups [6]. Each process of care
was analyzed separately. For the analysis of each care
process, patients were excluded who were never eligible
to be prompted for that process (e.g. patients who never
received antibiotics never triggered prompting to con-
sider stopping antibiotics).
To perform a mediating effects analysis, we constructed
a logistic regression base model containing group assign-
ment and APACHE IV predicted hospital mortality. We
then added categorical variables for empiric antibiotic
duration to the model to determine their mediating effect
on the adjusted odds ratio of death for the prompted
group variable (i.e. the degree to which the adjusted odds
ratio for death for the prompted group changed with
the addition of empiric antibiotic categories). In addition,
we constructed a separate logistic regression model that
did not include the group variable to examine whether
empiric antibiotic duration categories were independent
predictors of risk-adjusted mortality. The category repre-
senting the shortest duration of antibiotics was used as a
reference for each mediating effects regression model
described above.
Similar models were created to examine the separate
mediating effect of 1) mechanical ventilation, and 2) centralvenous catheters on the group odds ratio of death. For
patients who received mechanical ventilation at any time
during their ICU admission, we determined whether
prompting was associated with an increased proportion
of patients liberated from mechanical ventilation.
Previously, we demonstrated a significant increase in
the proportion of eligible prompted group patients who
received DVT and stress ulcer prophylaxis [6]. However,
the high proportion of patients in both groups who
received these therapies made it difficult to include them
in a mediating effects model. Prompting did not signifi-
cantly reduce Foley urinary catheter duration, so this too
was not explored as a potential mediator.
We determined three characteristics of experience for
each attending physician: number of “on-service” MICU
days from 6/25/08-6/24/09 (one full year prior to the
prompting intervention), number of years since pulmon-
ary/critical care fellowship completion, and a model that
included both of these variables. We constructed logistic
regression models by weighting the above variables
based on the percentage each patient was exposed to
each attending during their MICU stay.
We used a χ2 test to compare categorical variables.
For logistic regression models, odds ratios (OR) are
reported with 95% confidence intervals (CIs). All tests
were two-tailed, and a P value of <0.05 was considered
significant. Analyses were performed using SAS (ver-
sion 9.2, Cary, NC).
Results
Two hundred sixty-five patients were included in the
study, 140 in the prompted group and 125 in the control
group. Baseline characteristics were not different be-
tween the prompted and control groups (Table 1). As
previously reported, a prompter was present on 67.9%
of prompted group daily rounds. Overall, prompting
was required on 64.7% of patient-days. Empiric antibiotic
prompting was required on 36.3% patient-days, mechan-
ical ventilation prompting was required on 14.1%
Table 3 Multivariable analysis of the effect of
intervention group and empiric antibiotics on
hospital mortality
OR (95% CI) P value
Intervention effect base model:
Prompted group 0.41 (0.18-0.92) 0.032
APACHE IV predicted mortality 47.8 (10.3-222) <0.001
Empiric antibiotics mediating effect model:a
Prompted group 0.50 (0.21-1.2) 0.11
APACHE IV predicted mortality 37.0 (7.6-180) <0.001
Empiric antibiotics 4–6days 2.1 (0.76-6.0) 0.15
Empiric antibiotics ≥7days 2.5 (0.92-6.6) 0.074
Independent empiric antibiotics model:a
APACHE IV predicted mortality 30.5 (6.6-140) <0.001
Empiric antibiotics 4–6days 2.3 (0.81-6.3) 0.12
Empiric antibiotics ≥7days 3.1 (1.2-8.0) 0.019
a Category 1 (empiric antibioticduration 1–3days) used as reference
OR: Odds ratio ofdeath. CI: confidence interval.
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required on 25.7% patient-days [6]. Process of care and
clinical outcomes also have been previously reported [6].
Attending experience did not differ between the
prompted and control teams, and none of the attending
variables were predictors of hospital mortality.
Empiric antibiotics
One hundred eighty-three patients in this study received
empiric antibiotics on at least one day during their
MICU admission. In this sub-group of patients who
received empiric antibiotics, there were also no differ-
ences in baseline characteristics. The percentage of
patients who received empiric antibiotics was not statis-
tically different in the prompted and control groups
(64.3% vs. 74.4%, P=0.075). As previously reported,
prompting to consider empiric antibiotic discontinuation
was required on 36.3% of patient-days, while median
empiric antibiotic duration was reduced to two days in
the prompted group compared to three days in the con-
trol group [6].
As empiric antibiotic duration increased, unadjusted hos-
pital mortality concomitantly increased (P for trend<0.001)
(Table 2). Prompting was associated with reduced risk-
adjusted odds of death in all patients who received
empiric antibiotics (OR 0.41, 95% CI 0.18-0.92, P=0.032),
and in patients who received empiric antibiotics for
1–3 days (OR 0.17, 95% CI 0.04-0.75, P=0.019). There
were no statistically significant differences in mor-
tality between the prompted and control groups in
patients who received empiric antibiotics for 4–6 or
≥7days, respectively.
In the baseline mortality model (adjusted only for
APACHE IV score), the adjusted odds ratio of death was
0.41 (95% CI 0.18-0.93, P=0.032) for patients in the
prompted group (Table 3). When empiric antibiotic dur-
ation categories were added to this model, the mortality
difference was attenuated (OR 0.50, 95% CI 0.21-1.2,
P=0.11). The percent difference in the adjusted OR of
death between the baseline model and full model
explained by the addition of empiric antibiotic categories
was 15.2%. Thus, 15.2% of the risk-adjusted mortality
reduction associated with prompting can be accounted
for by the reduction of empiric antibiotic duration
with prompting.Table 2 Hospital mortality according to duration








a P for trend<0.001.In the empiric antibiotics-only model, we found that
empiric antibiotic duration of ≥7days was an independ-
ent predictor of risk-adjusted mortality (OR 3.1, 95%
CI 1.2-8.0, P=0.019), while empiric antibiotic duration of
4–6days increased the odds of death but was not sta-
tistically significant (Table 3). The results were similar
in sensitivity analyses using alternative categorization
schemes for empiric antibiotic duration.
Mechanical ventilation
Seventy-seven patients (29% of the total study population)
received mechanical ventilation through an endotracheal
or tracheotomy tube during their MICU admission. As
previously reported, prompting to consider performing a
spontaneous breathing trial was required on 14.1% of
patient-days, while median ventilator-free days was higher
in the prompted group compared to control (22 [14–26]
days vs. 16 [0–21.5]days, P=0.028) [6].
There was no statistically significant difference in the
percentage of patients in the prompted group who were
liberated from mechanical ventilation compared to con-
trol (78.0% vs. 66.7%, P=0.31). After adjustment for
APACHE IV severity, the odds ratio (95% CI) of being
liberated from mechanical ventilation in the prompted
group was 1.7 (0.5-5.7, P=0.38). The number of mechan-
ically ventilated patients was too small to conduct formal
mediation analyses to determine to what degree the
higher rate of liberation from mechanical ventilation
explained the overall benefit of prompting.
Central venous catheters
One hundred three patients had a central venous cath-
eter in place during their MICU admission, including
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of patients who received central venous catheters was
not statistically different in the prompted and control
groups (39.3 vs. 38.4%, P=0.88). As previously reported,
prompting to consider removing a CVC was required on
25.7% of patient-days, while median CVC duration was
shortened to three days in the prompted group com-
pared to five days in the control group [6].
As central venous catheter duration increased, a corre-
sponding increase in the hospital mortality rate was seen
(CVC duration 1–3days, 15.8%; CVC duration 4–6days,
23.8%; and CVC duration ≥7days, 36.0%, respectively;
P for trend=0.043). In the base model, among all patients
with a CVC, the prompted group had a risk-adjusted
mortality odds ratio (95% CI) of 0.48 (0.17-1.4, P=0.17).
In the model that included central venous catheter dur-
ation categories, the mortality reduction in the interven-
tion group was slightly attenuated, OR to 0.54 (0.18-1.6,
P=0.27). Neither model was statistically significant.
Discussion
Our exploratory analyses suggest that the lower risk-
adjusted mortality seen in the intervention group that
received prompting was due to multiple improvements
in processes of care, each of which may have had small,
incremental contributions to lowering mortality. Redu-
cing empiric antibiotic duration appears to have had the
largest individual effect, but reducing the duration of cen-
tral venous catheters also may have contributed. While
the higher rate of liberating patients from mechanical
ventilation in the intervention group likely contributed to
lower mortality, we were not able to assess the magnitude
of this in formal mediation analyses because of the small
number of mechanically ventilated patients.
There are two central findings related to empiric anti-
biotic utilization. First, a strategy of prompting that
shortened the duration of empiric antibiotics may ac-
count for some of the mortality benefits seen with the
prompting intervention. To our knowledge, this is the
first report that an intervention strategy that reduces
empiric antibiotic duration may mediate a reduction in
risk-adjusted mortality. Concern for clinical deterior-
ation after discontinuing empiric antibiotics leads many
providers to continue them even in the face of docu-
mented negative microbial cultures [9,24-26]. Our study
contradicts this concern and suggests that strategies that
reduce empiric antibiotic overuse may prevent poten-
tially harmful consequences.
This conclusion must be interpreted cautiously, becau-
seduration of empiric antibiotics may be a marker of
ongoing or worsening severity of illness. At a minimum,
however, shortening empiric antibiotic duration did
not worsen mortality. This result is consistent with
prior research that has shown that when infection washighly suspected, shortening antibiotic therapy based on
procalcitonin measurement did not increase mortality
[10,11].
In addition, we demonstrated that prolonged empiric
antibiotic duration is an independent predictor of risk-
adjusted mortality. This finding supports prior research
that has shown an association between prolonged use of
empiric antibiotics and mortality [8,9]. In particular,
Aarts and coworkers reported that prolonged empiric
antibiotic therapy (>4days) in patients without noso-
comial infection was associated with an almost 4-fold
increase in the age- and risk-adjusted odds of death that
almost reached statistical significance [9].
The second main finding is that a large, unexplained
association between prompting and mortality remained
after adjusting for empiric antibiotic utilization. There
may be several reasons for this. Significant synergistic
effects among empiric antibiotics, mechanical ventila-
tion, and central venous catheters may exist, given these
processes’ closely related clinical utilization. Also, we
had imperfect measures of potential mediating care pro-
cesses. For example, the duration of empiric antibiotics
may not capture all possible information about the effect
of empiric antibiotics on the prevention of antibiotic-
related side effects, such as antibiotic resistance, that
may then contribute to mortality. In addition, the study
definition of what constituted an empiric antibiotic was
intentionally broad (antibiotics administered without
culture-documented infection). Had a more narrow def-
inition been employed, empiric antibiotic duration may
possibly have had a greater mediating effect.
Moreover, we do not know which specific reductions
in empiric antibiotics were attributable to prompting,
since an individual prompt may have impacted other
processes of care or the empiric antibiotic management
for other patients [6]. As a result, prompting may lead
to other unmeasured changes in physician behavior.
For example, prompting to discontinue empiric antibio-
tics for an individual patient may have had a learned
behavioral effect on the caregiver to consider antibiotic
changes in other patients prior to further prompting.
Finally, the full effect of prompting on mortality may be
the result of numerous small, incremental improvements
that escaped measurement. These issues deserve further
study in large, multi-center trials that are powered not
only for mortality or other clinical outcomes, but also
adequate to analyze causal mechanisms more completely.
Our study had several potential limitations, some
described previously [6]. It was based on a small cohort
conducted at a single institution, limiting statistical
power in these exploratory analyses. In particular, ana-
lysis of mechanical ventilation and central venous cath-
eter analyses was difficult due to low statistical power. In
addition, the APACHE IV prediction model employed
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admission [18,19]. Ongoing severity-of-illness, which
wedid not measure, could have affected the delivery of
the processes of care that we investigated.
We did not adjust variances for clustering of patients
within clinicians. Since the treatments and tests received
by patients cared for by the same physician can be corre-
lated, lack of adjustment for clustering can overestimate
tests of statistical significance. However, as is typical of
critical care practice, patients in our study were fre-
quently cared for by multiple physicians (and other care
providers)during their ICU stay. There is no established
method to account for clustering when there are mul-
tiple providers per patient and the configuration of pro-
viders changes across patients (i.e. there are not fixed
teams). The fact that multiple physicians cared for
patients during their stay decreases the influence of any
individual physician, so it is unlikely that adjustment for
clustering would significantly alter our results.
It is possible that if practice patterns differed by team,
this could have confounded the results of the study. This
issue was addressed in four ways. First, we randomly
assigned the prompted and control teams after physician
clinical schedules were published. Second, there were no
differences between the two teams in attending phys-
ician experience or the effect of attending experience on
mortality. Third, no other structure or process improve-
ments affecting the MICU teams were made during the
study. Finally, attending physicians were only “on-
service” for one to two weeks, with different attending
physicians covering the weekends. Due to this frequent
rotation, many patients were likely treated by more than
one attending, further diluting any practice pattern con-
founding. The possibility that some unmeasured con-
founding exists remains as a limitation to this study.
Conclusions
In summary, our findings support the hypothesis that
some of the favorable mortality effects of a prompting
intervention were due to reduced empiric antibiotic dur-
ation. However, much of the effect of prompting on
mortality remained unexplained. This could suggest that
multiple improvements in, and synergy between, pro-
cesses of care may have had small, incremental contribu-
tions to lowering mortality. We believe the data warrant
future investigations of whether strategies that specific-
ally reduce empiric antibiotic duration and improve
other processes of care lead to improved ICU outcomes.
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